The agreement enables Gene Logic to receive success-based milestone payments for each drug candidate that Abbott returns to clinical development and royalties for each drug product candidate that becomes a marketed drug, a release stated.
Business
The agreement enables Gene Logic to receive success-based milestone payments for each drug candidate that Abbott returns to clinical development and royalties for each drug product candidate that becomes a marketed drug, a release stated.